retatrutide glp-1 gip glucagon triple agonist Dual and Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Eli Lilly just announced striking

The new pills are comparable to the injection

Research facilities should maintain documented temperature logs for both freezer storage of lyophilized material and refrigerated storage of reconstituted compound

ADM unveiled GLP-1-supportive solutions in October 2024, including more than 25 market-ready food and supplement concepts for brand customers developing products for GLP-1 users

With muscle preservation during GLP-1 therapy being a major concern, retatrutide's glucagon component is of particular interest

If you observe any discoloration or cloudiness in your compounded semaglutide, consult your healthcare provider before using it

The FDA recently announced that it will take decisive steps to restrict GLP-1 active pharmaceutical ingredients intended for use in non-FDA approved compounded drugs that are being mass-marketed by companies. The regulator called out Hims & Hers by name and put other compounding pharmacies on notice, too